AstraZeneca
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-05-01
- Last Posted Date
- 2017-01-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 561
- Registration Number
- NCT00891462
- Locations
- 🇨🇦
Forest Investigative Site, Toronto, Canada
AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2009-04-30
- Last Posted Date
- 2018-06-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 88
- Registration Number
- NCT00890825
- Locations
- 🇪🇸
Research Site, Málaga, Spain
A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder
- Conditions
- Bipolar Disorders
- First Posted Date
- 2009-04-27
- Last Posted Date
- 2010-12-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 152
- Registration Number
- NCT00888264
- Locations
- 🇧🇪
Research Site, Zoutleeuw, Belgium
A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2009-04-24
- Last Posted Date
- 2009-07-16
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 64
- Registration Number
- NCT00887770
- Locations
- 🇬🇧
Research Site, London, United Kingdom
Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy
- First Posted Date
- 2009-04-24
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 102
- Registration Number
- NCT00888082
- Locations
- 🇹🇷
Research Site, Kayseri, Turkey
AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2009-08-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 48
- Registration Number
- NCT00886756
- Locations
- 🇬🇧
Research Site, London, United Kingdom
10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)
- Conditions
- Breast Cancer
- First Posted Date
- 2009-04-22
- Last Posted Date
- 2010-06-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1114
- Registration Number
- NCT00885612
- Locations
- 🇰🇷
Research Site, Ulsan, Korea, Republic of
Positron Emission Tomography (PET) Study
- First Posted Date
- 2009-04-22
- Last Posted Date
- 2009-09-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 11
- Registration Number
- NCT00886067
- Locations
- 🇸🇪
Research Site, Stockholm, Sweden
Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients
- First Posted Date
- 2009-04-22
- Last Posted Date
- 2010-12-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 26
- Registration Number
- NCT00886366
- Locations
- 🇸🇪
Research Site, Goteborg, Sweden
Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Drug: Placebo plus metformin IR
- First Posted Date
- 2009-04-22
- Last Posted Date
- 2015-06-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 166
- Registration Number
- NCT00885378
- Locations
- 🇺🇸
John Muir Physician Network Clinical Research Center, Concord, California, United States
🇺🇸Wells Institute For Health Awareness, Kettering, Ohio, United States
🇺🇸Newark Physician Associates, Newark, Ohio, United States